UNSPSC 51373309: Acetaminophen/caffeine/dihydrocodeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373309 Acetaminophen/caffeine/dihydrocodeine is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—represents a public health procurement unrelated to the pharmaceutical combination the code nominates. Naloxone is an opioid antagonist used in overdose response, and Safe Drug Deactivation Systems are medical waste handling equipment; neither falls within the acetaminophen/caffeine/dihydrocodeine therapeutic class. The mismatch suggests either a tagging error in the source data or a jurisdiction's use of the code outside its intended scope.

Seminole County, Florida released IFB60459723LAS on June 30, 2026 (note: the due date in the source records July 26, 2023, which appears to be a data-entry inconsistency), requesting 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually via competitive bid, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with an optional one-year renewal, E-Verify and drug-free workplace compliance requirements, and potential FEMA funding with associated federal environmental compliance obligations. Bidders must include all shipping and delivery costs in their proposals and maintain workers' compensation, commercial general liability, and professional liability insurance. The source reflects no other recent state or local opportunities under this code, no evidence of repeat issuing bodies, and no geographic concentration beyond this single Florida procurement. The code does not show current market activity aligned with its nominal pharmaceutical scope.